KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Finished Goods (2016 - 2025)

Historic Finished Goods for Edwards Lifesciences (EW) over the last 12 years, with Q3 2025 value amounting to $642.2 million.

  • Edwards Lifesciences' Finished Goods rose 510.64% to $642.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $642.2 million, marking a year-over-year increase of 510.64%. This contributed to the annual value of $609.4 million for FY2024, which is 1916.31% up from last year.
  • Per Edwards Lifesciences' latest filing, its Finished Goods stood at $642.2 million for Q3 2025, which was up 510.64% from $630.5 million recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Finished Goods peaked at $668.7 million during Q1 2024, and registered a low of $511.4 million during Q4 2023.
  • Over the past 3 years, Edwards Lifesciences' median Finished Goods value was $610.2 million (recorded in 2024), while the average stood at $602.6 million.
  • Its Finished Goods has fluctuated over the past 5 years, first soared by 1916.31% in 2024, then tumbled by 1109.62% in 2025.
  • Quarter analysis of 3 years shows Edwards Lifesciences' Finished Goods stood at $511.4 million in 2023, then rose by 19.16% to $609.4 million in 2024, then increased by 5.38% to $642.2 million in 2025.
  • Its last three reported values are $642.2 million in Q3 2025, $630.5 million for Q2 2025, and $594.5 million during Q1 2025.